McKesson Corp (MCK) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised Earnings ...

McKesson Corp (MCK) reports a 10% revenue increase and raises earnings guidance, despite challenges in the medical surgical ...

McKesson raises 2026 EPS guidance to $38.35–$38.85 while advancing oncology and specialty platforms

Q2 2026 Management View Brian Tyler, CEO, reported "strong second quarter results, which reflect sustained momentum in our ...

McKesson raises annual profit forecast on robust demand for specialty drugs

() -Drug distributor McKesson raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology ...
Zacks Investment Research on MSN

McKesson (MCK) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2025, McKesson (MCK) reported revenue of $103.15 billion, up 10.1% over the same period last year. EPS came in at $9.86, compared to $7.07 in the year-ago quarter. The ...